Delivery Order SPE2DB20D1051-SPE2DB25FD8ES

Award Date 5/20/25
Potential Completion Date 5/21/25
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Depakote DR 125 mg sprinkle capsules, with a ceiling value of $1,824.98 and a period of performance through May 1, 2025. The contract is a firm fixed-price, non-set-aside award. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Depakote DR 125 mg sprinkle capsules. The contract has a firm fixed-price, with a ceiling value of $4,739.66 and a performance period through March 19, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,214.29 firm fixed-price contract is for the delivery of Depakote DR 125 mg medication sprinkle capsules. It is an open competition contract, with no set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves...
This federal contract award is for the delivery of 100 bottles of Depakote DR 125 mg sprinkle capsules to the Defense Logistics Agency (DLA). The $4,505.10 firm fixed-price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of January 11, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a $1,147.13 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DEPAKOTE DR 125 MG SPRINKLE CP 100S, a generic pharmaceutical product. The contract has an ultimate completion date of April 8, 2025 and does not utilize any set-aside designation. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $1,064.16, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Depakote DR 125 mg sprinkle capsules, a medication used for various neurological and psychiatric conditions. The contract has an ultimate completion date of August 10, 2022 and is a Firm Fixed Price (FFP) agreement. The award is not associated with...
This is a $2,355.92 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the supply of Depakote DR 125 mg sprinkle capsules, a neurological medication, to support military and government healthcare programs. The delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,711.55, is a Firm Fixed Price Delivery Order for the supply of Depakote DR 125 mg sprinkle capsules. The contract has a performance period through March 13, 2025 and does not have a set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Depakote DR 125 mg sprinkle capsules. The contract has a ceiling value of $15,202.89 and a period of performance ending on January 3, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,182.63 firm fixed-price delivery order contract is for the supply of Depakote DR 125 mg sprinkle capsules. The ultimate completion date is February 3, 2025. Amerisourcebergen is the prime contractor on this award, which is not designated as a set-aside contract. The company also holds a $999,999,999 Indefinite...
  • SPE2DB20D1051
    Indefinite Delivery Contract
  • SPE2DB20D1051-SPE2DB25FD8ES
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Depakote DR 125 mg sprinkle capsules, a neurological medication. The contract is a firm fixed-price, non-set-aside award with a ceiling value of $1,787.78 and an ultimate completion date of May 21, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 8/24/25, 1:09 AM